Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 8.86 is 30% below its 5-year average of 12.70, near the low end of its 5-year range (7.10–39.39).
As of the fiscal period ended Tuesday, June 30, 2026. 9.20% below its 12-month average of 9.76.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 8.86.
CURRENT RATIO
8.86
CURRENT RATIO AVG TTM
9.76
CURRENT RATIO AVG 3Y
10.35
CURRENT RATIO AVG 5Y
12.70
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-9.20%
CURRENT VS 3Y AVG
-14.41%
CURRENT VS 5Y AVG
-30.20%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.51
median of 734 covered companies
CURRENT VS SECTOR MEDIAN
+152.51%
vs the sector median at left
Olema Pharmaceuticals, Inc.
Market Cap
$714.33M
Current Ratio
8.86
TTM Avg
9.76
3Y Avg
10.35
5Y Avg
12.70
Market Cap
$717.44M
Current Ratio
1.03
TTM Avg
1.26
3Y Avg
1.17
5Y Avg
1.16
Market Cap
$719.59M
Current Ratio
19.31
TTM Avg
14.05
3Y Avg
7.67
5Y Avg
5.91
Market Cap
$720.94M
Current Ratio
4.48
TTM Avg
5.45
3Y Avg
6.78
5Y Avg
8.00
Market Cap
$736.49M
Current Ratio
0.95
TTM Avg
4.92
3Y Avg
2.98
5Y Avg
5.72
Market Cap
$737.40M
Current Ratio
19.69
TTM Avg
6.38
3Y Avg
9.16
5Y Avg
11.87
Market Cap
$689.73M
Current Ratio
14.20
TTM Avg
2.62
3Y Avg
2.46
5Y Avg
2.12
Market Cap
$744.71M
Current Ratio
16.09
TTM Avg
8.04
3Y Avg
7.87
5Y Avg
9.13
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | $714.33M | 8.86 | 9.76 | 10.35 | 12.70 |
| Collegium Pharmaceutical, Inc. (COLL)vs › | $717.44M | 1.03 | 1.26 | 1.17 | 1.16 |
| Avalo Therapeutics, Inc. (AVTX)vs › | $719.59M | 19.31 | 14.05 | 7.67 | 5.91 |
| Cytek Biosciences, Inc. (CTKB)vs › | $720.94M | 4.48 | 5.45 | 6.78 | 8.00 |
| Achieve Life Sciences, Inc. (ACHV)vs › | $736.49M | 0.95 | 4.92 | 2.98 | 5.72 |
| Faeth Therapeutics, Inc. (FTH)vs › | $737.40M | 19.69 | 6.38 | 9.16 | 11.87 |
| Anteris Technologies Global Corp. (AVR)vs › | $689.73M | 14.20 | 2.62 | 2.46 | 2.12 |
| Helus Pharma Inc. (HELP)vs › | $680.31M | 10.97 | 8.63 | 10.75 | 10.66 |
| Candel Therapeutics, Inc. (CADL)vs › | $744.71M | 16.09 | 8.04 | 7.87 | 9.13 |
| Annexon, Inc. (ANNX)vs › | $677.49M | 5.53 | 8.02 | 10.47 | 14.43 |
Current Ratio
8.86
Quick Ratio
8.86
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 8.86 |
| 2026-03-31 | 10.88 |
| 2025-12-31 | 9.95 |
| 2025-09-30 | 8.03 |
| 2025-06-30 | 11.09 |
| 2025-03-31 | 15.22 |
| 2024-12-31 | 10.50 |
| 2024-09-30 | 7.10 |
| 2024-06-30 | 9.13 |
| 2024-03-31 | 9.61 |
| 2023-12-31 | 12.33 |
| 2023-09-30 | 17.66 |
| 2023-06-30 | 11.56 |
| 2023-03-31 | 9.76 |
| 2022-12-31 | 12.62 |
| 2022-09-30 | 17.93 |
| 2022-06-30 | 19.75 |
| 2022-03-31 | 26.57 |
| 2021-12-31 | 32.23 |
| 2021-09-30 | 34.63 |
| 2021-06-30 | 39.39 |
| 2021-03-31 | 62.59 |
| 2020-12-31 | 74.62 |
| 2020-09-30 | 24.48 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 0.07 |
